Corona Remedies IPO allotment scheduled for today along with status, GMP, and expected listing info

The pharmaceutical company is expected to finalize its IPO allotment today. The issue received an overwhelming response, being subscribed over 137 times, driven mainly by QIBs and NIIs, which oversubscribed their quotas by more than 200 times.

Corona Remedies IPO, valued at ₹655.37 crore and priced between ₹1,008–1,062 per share with a lot size of 120 shares, received bids for 62.65 crore shares against 45.72 lakh shares on offer. QIBs led the demand with subscriptions of 278.52 times, followed by NIIs at 208.88 times, while the retail category was subscribed 28.73 times. With the bidding now closed, investors are awaiting the allotment outcome, which is expected later today. Once finalised, allotment status can be checked on the official websites of BSE, NSE, or Bigshare Services, the registrar for the IPO. Meanwhile, unlisted shares are trading around ₹1,357 in the grey market, indicating a grey market premium of ₹295 per share, roughly 27.78% above the upper price band. Corona Remedies shares are scheduled to list on BSE and NSE on Monday, December 15, 2025, with potential listing gains if grey market trends continue, though GMP is only indicative.